Galectin Therapeutics Inc

GALT NASDAQ Santé & Biotech États-Unis US3632252025
2.52 $
8.36 %

Galectin Therapeutics Inc se concentre sur le développement de traitements basés sur les galectines pour les maladies fibrotiques et le cancer.

Performance & Momentum

6 Months 54.26 %
1 Year 95.35 %
3 Years 58.49 %
5 Years 34.55 %

Similar stocks to Galectin Therapeutics Inc

Anantys Community

Be the first to share your analysis on Galectin Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases